Regeneron Pharmaceuticals recently saw its Fair Value price target increased from $722.20 to $735.72. This change comes on ...
Second-generation anti-VEGF agents, like aflibercept 8 mg and faricimab, show improved efficacy and treatment durability in ...
Q3 2025 Sales Call October 30, 2025 4:00 AM EDTCompany ParticipantsCraig Marks - Head of Investor RelationsRichard Saynor ...
As of October of this year, seven states have passed EPR laws (i.e., California, Colorado, Maine, Maryland, Minnesota, Oregon, and Washington), ...
Sales Result/9 Month figures Sandoz delivers a further acceleration in sales growth; full-year margin guidance upgraded 30-Oct-2025 / 07:00 CET/CEST Release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback